1. Home
  2. LGND vs TIGR Comparison

LGND vs TIGR Comparison

Compare LGND & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • TIGR
  • Stock Information
  • Founded
  • LGND 1987
  • TIGR 2014
  • Country
  • LGND United States
  • TIGR Singapore
  • Employees
  • LGND N/A
  • TIGR N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • TIGR Investment Bankers/Brokers/Service
  • Sector
  • LGND Health Care
  • TIGR Finance
  • Exchange
  • LGND Nasdaq
  • TIGR Nasdaq
  • Market Cap
  • LGND 2.0B
  • TIGR 1.8B
  • IPO Year
  • LGND 1992
  • TIGR 2019
  • Fundamental
  • Price
  • LGND $102.19
  • TIGR $8.12
  • Analyst Decision
  • LGND Strong Buy
  • TIGR Buy
  • Analyst Count
  • LGND 8
  • TIGR 2
  • Target Price
  • LGND $144.71
  • TIGR $8.54
  • AVG Volume (30 Days)
  • LGND 118.3K
  • TIGR 3.7M
  • Earning Date
  • LGND 05-08-2025
  • TIGR 05-30-2025
  • Dividend Yield
  • LGND N/A
  • TIGR N/A
  • EPS Growth
  • LGND N/A
  • TIGR 93.97
  • EPS
  • LGND N/A
  • TIGR 0.46
  • Revenue
  • LGND $181,488,000.00
  • TIGR $374,147,409.00
  • Revenue This Year
  • LGND $17.68
  • TIGR $53.12
  • Revenue Next Year
  • LGND $18.69
  • TIGR $16.72
  • P/E Ratio
  • LGND N/A
  • TIGR $17.65
  • Revenue Growth
  • LGND 53.40
  • TIGR 61.42
  • 52 Week Low
  • LGND $77.43
  • TIGR $3.36
  • 52 Week High
  • LGND $129.90
  • TIGR $14.48
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • TIGR 40.48
  • Support Level
  • LGND $98.90
  • TIGR $8.41
  • Resistance Level
  • LGND $103.17
  • TIGR $9.06
  • Average True Range (ATR)
  • LGND 3.05
  • TIGR 0.48
  • MACD
  • LGND -0.27
  • TIGR -0.17
  • Stochastic Oscillator
  • LGND 31.94
  • TIGR 15.06

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About TIGR UP Fintech Holding Ltd representing fifteen

UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.

Share on Social Networks: